Lysosomal enzyme can bypass the blood-brain barrier and reach the CNS following intranasal administration.
about
Intranasal Delivery of Recombinant AAV Containing BDNF Fused with HA2TAT: a Potential Promising Therapy Strategy for Major Depressive Disorder.Perillyl Alcohol and Its Drug-Conjugated Derivatives as Potential Novel Methods of Treating Brain MetastasesSystemic gene delivery to the central nervous system using Adeno-associated virus.Inhibition of Let7c microRNA is neuroprotective in a rat intracerebral hemorrhage modelDirect nose to brain drug delivery via integrated nerve pathways bypassing the blood-brain barrier: an excellent platform for brain targeting.Rapid intranasal delivery of chloramphenicol acetyltransferase in the active form to different brain regions as a model for enzyme therapy in the CNS.Standardization of α-L-iduronidase enzyme assay with Michaelis-Menten kinetics.Recent advances in gene therapy for lysosomal storage disorders.Intranasal gene delivery for treating Parkinson's disease: overcoming the blood-brain barrier.Lysosomal enzyme replacement therapies: Historical development, clinical outcomes, and future perspectives.Improving drug delivery technology for treating neurodegenerative diseases.High-dose enzyme replacement therapy in murine Hurler syndromeProlonged Expression of Secreted Enzymes in Dogs After Liver-Directed Delivery of Sleeping Beauty Transposons: Implications for Non-Viral Gene Therapy of Systemic Disease.Intranasal Adeno-Associated Virus Mediated Gene Delivery and Expression of Human Iduronidase in the Central Nervous System: A Noninvasive and Effective Approach for Prevention of Neurologic Disease in Mucopolysaccharidosis Type I.Enzyme replacement in neuronal storage disorders in the pediatric population.Guanidinylated Neomycin Conjugation Enhances Intranasal Enzyme Replacement in the Brain.Methods of Drug Delivery in Neurotrauma.
P2860
Q27335060-E4F1FE7A-D84C-452D-A403-A27ADF19CD32Q28072442-EBCC365F-A7A4-48BD-8F97-BD1C1A4C6252Q33695674-41F00D6B-7493-484E-90B3-24A84DF9DBE8Q33799893-E72A34DB-3C41-44EA-AA8C-ABB293483EFBQ34339313-8D566F51-EAA5-43FD-83BA-8026D8BFB840Q36471581-BE5AEA42-8A47-477C-ADF1-520BF9158A14Q38170826-AA80E313-91BE-4050-9298-603C7DFC3BB8Q38546492-BA4CAD1C-5B40-475F-A96F-3C6F66CF4DE3Q38569775-38A92882-1555-405C-80E6-64C6554A873CQ38684097-67B87E4B-2D09-4EB0-B2ED-AC9BEE6F1C20Q38769989-B21C4C88-92FD-45EA-A8B0-AF050513DA30Q39381088-DBA3F03A-11E6-40D0-B96A-5CC81172C13CQ40191364-2727D647-95F2-420F-B9B3-CAEB4D3BA1DFQ40219437-48760705-AC81-43C6-9CBB-DFB7B245F238Q43948150-87DA1B18-D329-452C-AD0B-B0856125BF9BQ45931498-72079762-5AC8-4596-9C7F-A49BC41CCE14Q48525432-CADAAB9D-0F9C-4B91-9F03-ABCA82ABADD1
P2860
Lysosomal enzyme can bypass the blood-brain barrier and reach the CNS following intranasal administration.
description
2012 nî lūn-bûn
@nan
2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Lysosomal enzyme can bypass th ...... ing intranasal administration.
@ast
Lysosomal enzyme can bypass th ...... ing intranasal administration.
@en
Lysosomal enzyme can bypass th ...... ing intranasal administration.
@nl
type
label
Lysosomal enzyme can bypass th ...... ing intranasal administration.
@ast
Lysosomal enzyme can bypass th ...... ing intranasal administration.
@en
Lysosomal enzyme can bypass th ...... ing intranasal administration.
@nl
prefLabel
Lysosomal enzyme can bypass th ...... ing intranasal administration.
@ast
Lysosomal enzyme can bypass th ...... ing intranasal administration.
@en
Lysosomal enzyme can bypass th ...... ing intranasal administration.
@nl
P2093
P1476
Lysosomal enzyme can bypass th ...... ing intranasal administration.
@en
P2093
Daniel A Wolf
Elena L Aronovich
Leah R Hanson
R Scott McIvor
Walter C Low
William H Frey
Zhenhong Nan
P304
P356
10.1016/J.YMGME.2012.02.006
P577
2012-02-10T00:00:00Z